Table 2.
Multidisciplinary Heart Team Meeting Data and Outcomes
| Patient status at the time of meeting | |
| Inpatient | 119 (71.7) |
| Outpatient | 47 (28.3) |
| Number of attendees | |
| Total | 6 (5, 8) |
| Cardiac surgeons | 3 (1, 4) |
| Interventional cardiologists | 2 (2, 3) |
| General cardiologists | 1 (1, 2) |
| Formal Heart Team recommendation | |
| OMT | 23 (13.9) |
| PCI | 64 (38.6) |
| CABG | 44 (26.5) |
| Hybrid | 2 (1.2) |
| Othera | 4 (2.4) |
| Deferb | 29 (17.5) |
| Outcomes | |
| Successful PCI | 79 (47.6) |
| Heart team meeting to PCI, d | 1 (0, 3) |
| Successful CABG | 49 (29.5) |
| Heart Team meeting to CABG, d | 3 (1, 6) |
| Hybrid | 1 (0.6) |
| OMT only | 34 (20.5) |
| Length of stay, d (n=113) | 16 (11, 24) |
| 30‐d readmission rate | 31 (18.7%) |
| Outcomes of patients who underwent revascularization (n=129) | |
| Myocardial infarction | 5 (3.9) |
| Stroke | 3 (2.3) |
| AKI requiring dialysis | 3 (2.3) |
| Transfusion | 42 (32.6) |
| In‐hospital mortality | 5 (3.9) |
| 30‐d postprocedure mortality (n=125) | 6 (4.8) |
AKI indicates acute kidney injury; CABG, coronary artery bypass grafting; ICD, implantable cardioverter‐defibrillator; LVAD, left ventricular assist device; OMT, optimal medical therapy; PCI, percutaneous coronary intervention; and TAVR, transcatheter aortic valve replacement.
a
Other recommendations included TAVR (n=1), ICD (n=1), and LVAD (n=2).
b
Additional studies/evaluation needed.